Authors


Robert Iannone, MD, MSCE

Latest:

Results from the Subgroup Analysis of BECOME Caregiver Survey: Robert Iannone, MD, MSCE

The executive vice president of Global Head of Research and Development at Jazz Pharmaceuticals, spoke on the results from the BECOME study presented at the 2022 AES Conference. [WATCH TIME: 6 minutes]


June Halper, MSN, APC-C, MSCN, FAAN

Latest:

Advice for Physicians and the Multiple Sclerosis Community

The panel shares final advice for the multiple sclerosis community.


Mitchell Miglis, MD

Latest:

Mitchell Miglis, MD: A Bidirectional Link Between Autonomic Dysfunction, Hypersomnias

The autonomic disorders and sleep medicine specialist at Stanford University spoke about the overlap of autonomic disorders in sleep medicine, an often underrepresented portion of the sleep medicine field.



Regina Berkovich, MD, PhD

Latest:

Tools and Resources for the Management of MS

Drs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.


James W. Wheless, MD

Latest:

James W. Wheless, MD: Making Treatment Decisions in Epilepsy

The professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center discussed the decision-making process for choosing interventions for patients with epilepsy, and how to keep patients adherent.


Harald Hampel, MD, PhD, MA, MSc

Latest:

Harald Hampel, MD, PhD, MA, MSc on Advancements and Challenges in the Alzheimer Space

Hampel looks to the future of the Alzheimer space and sees promise, especially since there’s transfertilization from other advanced science fields in medicine like oncology, diabetes research and rheumatology.



Michael J. Thorpy, MBChB

Latest:

The Frequency of Occurrence of Narcolepsy Symptoms

Drs Thorpy, Dogan, Doghramji, and Kushida discuss the frequency of symptoms encountered in patients who are diagnosed with narcolepsy.


Barry J. Byrne, MD, PhD

Latest:

Challenges for the Neuromuscular Community Entering Treatment Era: Barry Byrne, MD, PhD

The chief medical advisor at the Muscular Dystrophy Association provided perspective on the upcoming meeting and the conversations surrounding new therapeutics for diseases that once had little to nothing. [WATCH TIME: 4 minutes]


Kathryn Davis, MD, MSTR

Latest:

Kathryn Davis, MD, MSTR: Off-Label Clobazam Use in Refractory Epilepsy

The associate professor of neurology and medical director of the epilepsy monitoring unit and Penn epilepsy surgical program at the University of Pennsylvania discussed the findings of a single-center review of off-label clobazam use for patients with drug-refractory epilepsy.


Dennis Lal, PhD

Latest:

Dennis Lal, PhD: The Value of Genetic Testing

In an interview with NeurologyLive, Dennis Lal, PhD, discusses the value of genetic testing and how it can optimize the way we develop clinical trials and test new therapies.


Stephanie J. Nahas, MD, MSEd

Latest:

The Changing Landscape of Preventative Migraine Treatments

A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.


James Wheless, MD

Latest:

James Wheless, MD: Consequences of Virtual Societal Meetings

The chief of pediatric neurology at the University of Tennessee Health Science Center, and director of the Comprehensive Epilepsy Program at Le Bonheur Children's Hospital spoke to the difficulty in connecting with colleagues with virtual meetings.


Patrick Campbell

Latest:

Stroke Risk Increase in Women With Elevated Lifetime Estrogen Exposure

Results from a recent study suggest that greater cumulative exposure to estrogen throughout a woman’s lifespan could increase her risk of stroke.


Alon Ironi

Latest:

Alon Ironi: Nerivio Migra Reduces Excess Medication Use in Migraine

The CEO and co-founder of Theranica discussed the migraine treatment device’s mechanism of action and its successes in reducing medication overuse headache.


Elizabeth A. Thiele MD, PhD

Latest:

The Approval of Fenfluramine for Treating Dravet Syndrome

Two experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.


Daniel J. Correa, MD, MSc

Latest:

Building a Neurology Space Inclusive of Diversity and Equity: Daniel Correa, MD, MSc

The neurologist at Montefiore Medical Center, Albert Einstein College of Medicine, discussed his experience in establishing a neurology department committee on diversity, equity, and inclusion. [WATCH TIME: 5 minutes]


Elizabeth Gerard, MD

Latest:

Elizabeth Gerard, MD: Considering Genetic Testing for Adult Epileptics

The associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine discussed the reasons an adult with epilepsy may seek genetic testing and what benefits it can provide.


Jennifer Robblee, MD

Latest:

Jennifer Robblee, MD: Adapting to Telemedicine in Migraine Care

The neurologist at the Barrow Neurological Institute gave her thoughts on how telemedicine has evolved throughout this year and its potential moving forward.


The section chief of pediatric neurology at Nationwide Children

Latest:

Long-Term CBD Use Appears Safe for Patients With Lennox-Gastaut Syndrome

The section chief of pediatric neurology at Nationwide Children’s Hospital shared his excitement about the approval of Epidiolex and its potential as a therapeutic.


Jill M. Farmer, DO, MPH

Latest:

Doctors, Remember Your Calling

It’s hard to be in medicine at the moment, and one day’s recognition is not enough. As your peer, I honor my fellow physicians today and every day.


Tal Arbel, PhD

Latest:

Tal Arbel, PhD: Approaching Multiple Sclerosis with Machine Learning

The director of the probabilistic vision group and medical imaging lab at McGill University spoke about how these learning methods can be used to predict future lesion activity and disability progression in MS.



Steven Shook, MD

Latest:

Steven Shook, MD: Managing Patients Via Telemedicine

The staff neurologist, Vice-Chair of Operations, and Quality Improvement Officer at Cleveland Clinic Neurological Institute detailed his experience managing patients with various conditions through a telemedicine platform.


Aimee W. Smith, PhD

Latest:

Aimee W. Smith, PhD: Caring for Pediatric Patients With Epilepsy

The assistant professor of psychology at East Carolina discussed how to improve adherence in young adults and children with epilepsy, and how physicians can go about checking quality of life in patients.


Wallace Brownlee, MBChB, PhD, FRACP

Latest:

Implications of Ozanimod Discontinuation Data for MS Care

Dr Brownlee shares his advice and recommendations from national MS society on providing cognitive care for patients suffering from MS.


Lara Jehi, MD

Latest:

Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome Optimization

Surgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?


Manish Shah MD, MPH

Latest:

Manish Shah MD, MPH: How Telemedicine Can Reduce ED Use in Dementia

The professor of emergency medicine at the University of Wisconsin-Madison School of Medicine and Public Health spoke about how telemedicine in senior living communities can effectively decrease ED use by individuals with dementia.


Rebecca Ichord, MD

Latest:

Rebecca Ichord, MD: Addressing Pediatric Stroke With Thrombectomy and Thrombolysis

The director of the Pediatric Stroke Program at CHOP discussed the findings of a single-center study exploring the incidence of children presenting with acute arterial ischemic stroke who may have been eligible for mechanical thrombectomy.

© 2024 MJH Life Sciences

All rights reserved.